DanielPetroniMDPhD

PubMed

• Varying Doses of Epicutaneous Immunotherapy With Viaskin Milk vs Placebo in Children With Cow's Milk Allergy: A Randomized Clinical Trial.
  Daniel Petroni, Philippe Bégin, J Andrew Bird, Terri Brown-Whitehorn, Hey J Chong, David M Fleischer, Rémi Gagnon, Stacie M Jones, Stephanie Leonard, Melanie M Makhija...> ;JAMA Pediatrics. 2024 Apr 1
• 14 citations
  Phase 3 Trial of Epicutaneous Immunotherapy in Toddlers with Peanut Allergy.
  Matthew Greenhawt, Sayantani B Sindher, Julie Wang, Michael O'Sullivan, George du Toit, Edwin H Kim, Deborah Albright, Sara Anvari, Nicolette Arends, Peter D Arkwright...> ;The New England Journal of Medicine. 2023 May 11
• Cyclosporine-Induced Posterior Reversible Encephalopathy Syndrome: An Adverse Effect in a Patient With Atopic Dermatitis.
  Clinton P Dunn, Charles L Dunn, Daniel H Petroni> ;Cutis. 2023 Mar 1
• 1 citations
  Identification of mast cell progenitor cells in the airways of individuals with allergic asthma.
  Ryan C Murphy, Yu-Hua Chow, Ying Lai, Taha Al-Shaikhly, Daniel H Petroni, Michele Black, Jessica A Hamerman, Adam Lacy-Hulbert, Adrian M Piliponsky, Teal S Hallstrand> ;Allergy. 2023 Feb 1
• 18 citations
  Safety of Epicutaneous Immunotherapy in Peanut-Allergic Children: REALISE Randomized Clinical Trial Results.
  Jacqueline A. Pongracic, Remi Gagnon, Gordon Sussman, Dareen Siri, Roxanne C. Oriel, Terri F. Brown-Whitehorn, Todd D. Green, Dianne E. Campbell, Sara Anvari, William ...> ;The Journal of Allergy and Clinical Immunology. in Practice. 2021 Nov 27
• 1 citations
  Unique basophil microRNA signature in chronic spontaneous urticaria patients who respond to omalizumab.
  Taha Al-Shaikhly, James W. MacDonald, Theo K. Bammler, Matthew C. Altman, Andrew G. Ayars, Daniel Petroni, Stephen A. Tilles, William R. Henderson> ;Clinical and Experimental Allergy. 2021 Sep 20
• 6 citations
  Use of omalizumab for management of idiopathic anaphylaxis: A systematic review and retrospective case series.
  Lauren W. Kaminsky, Kestutis Aukstuolis, Daniel Petroni, Taha Al-Shaikhly> ;Annals of Allergy, Asthma & Immunology. 2021 Jun 24
• 3 citations
  Extracellular vesicle microRNAs as predictors of response to omalizumab in chronic spontaneous urticaria
  Taha Al-Shaikhly, James W. MacDonald, Theo K. Bammler, Matthew C. Altman, Andrew G. Ayars, Daniel Petroni, Stephen A. Tilles, William R. Henderson> ;Allergy. 2021 Apr 1
• 15 citations
  Clinical response to omalizumab in patients with hereditary α-tryptasemia.
  Lybil B. Mendoza Alvarez, Russell Barker, Celeste Nelson, Tom DiMaggio, Kelly D. Stone, Joshua D. Milner, Jamie A. Rosenthal, Daniel Petroni, Sara C. Glover, Jonathan ...> ;Annals of Allergy, Asthma & Immunology. 2020 Jan 1
• 106 citations
  Phase 2a randomized, placebo-controlled study of anti-IL-33 in peanut allergy.
  Sharon Chinthrajah, Shu Cao, Cherie Liu, Shu-Chen Lyu, Sayantani B. Sindher, Andrew Long, Vanitha Sampath, Daniel Petroni, Marco Londei, Kari C. Nadeau> ;JCI Insight. 2019 Nov 14
• 8 citations
  Current management and use of oral immunotherapy in the United States for patients with peanut allergy.
  Michael S. Blaiss, Stephen A. Tilles, Daniel Petroni, Ellen Zigmont, Marie Cassese, Brian Kwak, Nicholas Georgitseas, Jay Liebermann> ;Allergy and Asthma Proceedings. 2019 Jul 23
• 19 citations
  Omalizumab for chronic urticaria in children younger than 12 years.
  Taha Al-Shaikhly, Jamie A. Rosenthal, Andrew G. Ayars, Daniel Petroni> ;Annals of Allergy, Asthma & Immunology. 2019 May 11
• 11 citations
  Twelve-year follow-up of omalizumab therapy for anaphylaxis in 2 patients with systemic mastocytosis.
  Gregory M. Constantine, Peter B. Bressler, Daniel Petroni, Dean D. Metcalfe, Melody C. Carter> ;The Journal of Allergy and Clinical Immunology. in Practice. 2019 Apr 1
• 144 citations
  Effect of Epicutaneous Immunotherapy vs Placebo on Reaction to Peanut Protein Ingestion among Children with Peanut Allergy: The PEPITES Randomized Clinical Trial
  David Fleischer, Matthew Greenhawt, Gordon Sussman, Philippe Bégin, Anna Nowak-Wegrzyn, Daniel Petroni, Kirsten Beyer, Terri F. Brown-Whitehorn, Jacques Hébert, Jonath...> ;JAMA. 2019 Mar 12
• 56 citations
  A Phase 2 Randomized Controlled Multisite Study Using Omalizumab-facilitated Rapid Desensitization to Test Continued vs Discontinued Dosing in Multifood Allergic Indiv...
  Sandra Andorf, Natasha Purington, Divya Kumar, Andrew Long, Katherine O'Laughlin, Scott H. Sicherer, Hugh A. Sampson, Antonella Cianferoni, Terri Brown Whitehorn, Dani...> ;Eclinicalmedicine. 2019 Jan 1
• 3 citations
  Immune modulation in a patient with Morquio syndrome treated with enzyme replacement therapy.
  Angela Sun, Walaa Alshuaibi, Daniel Petroni, Suzanne Skoda-Smith, Michael J. Goldberg, Susan Hale> ;The Journal of Allergy and Clinical Immunology. in Practice. 2018 Sep 1
• 16 citations
  FDA-approved peanut allergy treatment: The first wave is about to crest.
  Stephen A. Tilles, Daniel Petroni> ;Annals of Allergy, Asthma & Immunology. 2018 Jun 14
• 9 citations
  From clinical observations and molecular dissection to novel therapeutic strategies for primary immunodeficiency disorders.
  Hans D. Ochs, Daniel Petroni> ;American Journal of Medical Genetics. Part A. 2018 Apr 1
• 59 citations
  Eosinophilic esophagitis and symptoms possibly related to eosinophilic esophagitis in oral immunotherapy.
  Daniel Petroni, Jonathan M. Spergel> ;Annals of Allergy, Asthma & Immunology. 2018 Mar 1
• 13 citations
  Approach to the evaluation of adverse antibiotic reactions in patients with cystic fibrosis
  Daniel Petroni, Moira L. Aitken, Erin Ham, Sarah Chung, Lori Menalia, Matthew C. Altman, Andrew G. Ayars> ;Annals of Allergy, Asthma & Immunology. 2016 Oct 1
• Join now to see all